Biochemical Engineering Special Interest Group
biological engineering professionals
30 August 2017

First CAR-T Cancer Therapy Gets FDA Approval

U.S. regulators approved a revolutionary new cancer treatment from Novartis AG on Wednesday, the first in a group of coming therapies that offer breakthrough cures for dire cases as well as stratospheric costs. Known as CAR-T therapy, the treatment involves extracting a patient’s immune system cells and modifying them to attack aggressive blood cancers. Novartis will charge $475,000 for the one-time drug, called Kymriah, and said it’s developing programs where it will only get paid if patients respond to it. Source: Bloomberg 30/8/2017

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).